JENNIFER RADICE: Open Payments
NPI 1659345239 · CORYDON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $419 |
| Novo Nordisk Inc | 6 | $169 |
| ABBVIE INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: BREZTRI, AIRSUPRA, Ozempic, VRAYLAR, CAPLYTA, FARXIGA, Iovera, Wegovy.
Industry payments across IN — which companies pay providers there.
